All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F13%3AE0103556" target="_blank" >RIV/00843989:_____/13:E0103556 - isvavai.cz</a>

  • Result on the web

    <a href="http://dx.doi.org/10.1136/jnnp-2011-300376" target="_blank" >http://dx.doi.org/10.1136/jnnp-2011-300376</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1136/jnnp-2011-300376" target="_blank" >10.1136/jnnp-2011-300376</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy

  • Original language description

    Objective: To compare the effectiveness of levetiracetam (LEV) with extended-release sodium valproate (VPA-ER) and controlled-release carbamazepine (CBZ-CR) as monotherapy in patients with newly diagnosed epilepsy. Methods: This unblinded, randomised, 52-week superiority trial (NCT00175903) recruited patients (16years of age) with 2 unprovoked seizures in the previous 2years and 1 in the previous 6months. The physician chose VPA or CBZ as preferred standard treatment; each patient was randomised to standard treatment or LEV. The primary outcome was time to treatment withdrawal (LEV vs standard antiepileptic drugs (AEDs)). Analyses also compared LEV with VPA-ER, and LEV with CBZ-CR. Findings: 1688 patients (mean age 41years; 44% female) were randomisedto LEV (n=841) or standard AEDs (n=847). Time to treatment withdrawal was not significantly different between LEV and standard AEDs: HR (95% CI) 0.90 (0.74 to 1.08). Time to treatment withdrawal (HR (95% CI)) was 1.02 (0.74 to 1.41) for L

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FH - Neurology, neuro-surgery, nuero-sciences

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Others

  • Publication year

    2013

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of Neurology, Neurosurgery and Psychiatry

  • ISSN

    0022-3050

  • e-ISSN

  • Volume of the periodical

    84

  • Issue of the periodical within the volume

    n. 10

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    10

  • Pages from-to

    "p. 1138-1147"

  • UT code for WoS article

    000323779800017

  • EID of the result in the Scopus database